NATR as of Nov 2 · 18:43 ET
NATRNasdaqPharmaceutical Preparations
Natures Sunshine Products Inc · Brief
Next report
3 days
Nov 5 · after closeest.Q3 FY26
Expected move
No implied move.
1 of 8≥ implied
- avg implied
- ±15.1%
- avg realized
- ±11.7%
Aug 9 '24±24.7%▼−13.85%×0.56
Nov 7 '24±13.9%▲+7.50%×0.54
Mar 11 '25±16.2%▼−6.76%×0.42
Jul 31 '25±17.6%▲+12.78%×0.73
Q3 FY25±11.6%▲+30.52%×2.64
Q1 FY26±8.6%▼−1.28%×0.15
May 7 '26±6.9%▼−1.30%×0.19
Q2 FY26±21.3%▼−19.47%×0.92
quarterimplied−35%0+35%realized×
Q2 FY26±21.3%▼−19.47%×0.92
May '26±6.9%▼−1.30%×0.19
Q1 FY26±8.6%▼−1.28%×0.15
Q3 FY25±11.6%▲+30.52%×2.64
Jul '25±17.6%▲+12.78%×0.73
Mar '25±16.2%▼−6.76%×0.42
2 older reports
Nov '24±13.9%▲+7.50%×0.54
Aug '24±24.7%▼−13.85%×0.56
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.Bull2
+0.68%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
NATR report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.